Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children

Thanopoulos, Basil D.; Tsaousis, Georgios N.; Karanasios, Evangelos; Eleftherakis, Nikolaos G; Paphitis, Christodoulos

doi:10.1136/heart.89.8.918

Cited by 96 publications

(60 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The only serious concern of percutaneous pmVSD closure is the occurrence of cAVB. The cAVB rates reported in the literature vary between 0 and 5.7% [12][13][14][15][16][17][18][19]. However, this complication developed in six subjects with pmVSD (7.6%) in our series higher than in the literature.…”

Section: Discussioncontrasting

confidence: 80%

“…Statistical analysis showed that no variable predicted the occurrence of early complications. The rate of major complications reported in the literature ranges between 0 and 8.6% [10][11][12][13][14][15][16][17]. No significant valve regurgitation occurred in our series, and the incidence of residual shunting, which was 12.8% at discharge, decreased to 1.3% during the follow-up.…”

Section: Discussioncontrasting

confidence: 53%

“…When the Amplatzer PMVSD-O became available, the indications for percutaneous closure were also expanded to cases with only 1-2 mm between the defect and the aortic valve. Studies in the literature reported that the rate of successful closure was between 90 and 100% [12][13][14][15][16][17][18][19]. The data of percutaneous closure of pmVSD with VSD-O made in China are still limited.…”

Section: Discussionmentioning

confidence: 93%

See 2 more Smart Citations

Transcatheter closure of perimembranous ventricular septal defects (VSD) with VSD occluder: early and mid-term results

et al. 2011

View full text Add to dashboard Cite

Results of perimembranous ventricular septal defects (pmVSD) transcatheter closure have been reported in the literature, mostly with the Amplatzer VSD device (muscular or eccentric) (AGA Medical Corp., Golden Valley, MN, USA). However, the data of percutaneous closure of pmVSD with VSD occluder (VSD-O) made in China are still limited. We sought to analyze the safety, efficacy, and follow-up results of percutaneous closure of pmVSD with VSD-O made in China. Seventy-eight patients underwent percutaneous closure of pmVSD at our institution between February 2005 and June 2007. A VSD device made in china (Huayishengjie Medical Corp., Beijing, China) was used in all subjects. The mean age at closure was 11 years (range 2.5-44 years). The attempt to place the device was successful in 74 patients (94.9%). The median device size used was 8 mm (range 5-16 mm). No deaths occurred. Total occlusion rate was 62.8% at completion of the procedure, rising to 87.2% at discharge and 99% during the follow-up. A total of eight early complications occurred (10.3%), but in all subjects these were transient. The median follow-up was 32 months. The most significant complication was complete atrioventricular block (cAVB) in the early phase (five subjects, 6.4%) and during the follow-up (one subject, 1.3%), and there was no need for pacemaker implantation in six subjects. Logistic regression analysis showed that the only variable significantly associated with the occurrence of this complication was age at the time of the procedure (p = 0.025; OR 0.22). All subjects experiencing this problem were <5 years old. Percutaneous pmVSD closure used VSD-O made in China is associated with excellent success and closure rates, no mortality, and low morbidity. Nowadays, pmVSD percutaneous closure is a valuable alternative to surgery. Longer follow-up data and improvements in device characteristics are needed to reduce the risk of cAVB.

show abstract

Section: Discussioncontrasting

confidence: 80%

Section: Discussioncontrasting

confidence: 53%

Section: Discussionmentioning

confidence: 93%

See 1 more Smart Citation

Transcatheter closure of perimembranous ventricular septal defects (VSD) with VSD occluder: early and mid-term results

et al. 2011

View full text Add to dashboard Cite

show abstract

“…However, for large IVSD, the actual defect size or shunt amount was frequently underestimated to some extent because of the prolapsing aortic valve into the defect. 10,12,28, 29 Thus, in our study, in patients with IVSD ≥5 mm, a device that was 3-5 mm larger than the maximum size of the defect measured by TTE was chosen.…”

Section: Valvular Regurgitationmentioning

confidence: 99%

Transcatheter Closure of Intracristal Ventricular Septal Defect With Mild Aortic Cusp Prolapse Using Zero Eccentricity Ventricular Septal Defect Occluder

Chen

Liu

et al. 2015

Circ J

View full text Add to dashboard Cite

“…Posteriormente um dispositivo especificamente desenhado para a oclusão dos defeitos perimembranosos (CIVs perimembranosas), Amplatzer TM Membranous VSD Occluder (Aga Medical, Golden Valley, Estados Unidos) 18,19 , tornou-se disponível e trabalhos atestando sua segurança e eficácia, utilizando a técnica anterógrada, foram publicados. [19][20][21][22][23][24] O advento de dispositivos de malha de nitinol de duplo disco, desenhados especificamente para a oclusão de CIVs perimembranosas, possibilitou o fechamento retrógrado desse tipo morfológico de defeito. 24,25 O objetivo deste estudo foi apresentar a experiên-cia dos autores com a via retrógada e mostrar sua exequibilidade na oclusão dos diversos tipos de CIV.…”

Section: Key-wordsunclassified

Oclusão percutânea de comunicação interventricular por via arterial: técnica alternativa

Queiroz¹,

Simöes

Queiroz

et al. 2011

Rev. Bras. Cardiol. Invasiva

View full text Add to dashboard Cite

Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children

Cited by 96 publications

References 11 publications

Transcatheter closure of perimembranous ventricular septal defects (VSD) with VSD occluder: early and mid-term results

Transcatheter closure of perimembranous ventricular septal defects (VSD) with VSD occluder: early and mid-term results

Transcatheter Closure of Intracristal Ventricular Septal Defect With Mild Aortic Cusp Prolapse Using Zero Eccentricity Ventricular Septal Defect Occluder

Oclusão percutânea de comunicação interventricular por via arterial: técnica alternativa

Contact Info

Product

Resources

About